Benitec Biopharma Inc. Shares Outstanding (Cover Page)
Benitec Biopharma Inc. (BNTC) had Shares Outstanding (Cover Page) of 34.88 million shares as of 2026-09-04, per its 10-K filed 2026-09-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-09-14
- 2026-09-04: Entity Common Stock, Shares Outstanding 34.88M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 34.35M shares.
- 2026-02-06: Entity Common Stock, Shares Outstanding 34.35M shares.
- 2025-11-14: Entity Common Stock, Shares Outstanding 33.86M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-09-04 | 34.88M shares 10-K · filed 2026-09-14 |
| 2026-05-04 | 34.35M shares 10-Q · filed 2026-05-14 |
| 2026-02-06 | 34.35M shares 10-Q · filed 2026-02-12 |
| 2025-11-14 | 33.86M shares 10-Q · filed 2025-11-14 |
| 2025-09-17 | 26.25M shares 10-K/A · filed 2026-03-20 |
| 2025-05-14 | 25.60M shares 10-Q · filed 2025-05-14 |
| 2025-02-14 | 23.45M shares 10-Q · filed 2025-02-14 |
| 2024-11-12 | 23.22M shares 10-Q · filed 2024-11-14 |
| 2024-09-17 | 10.56M shares 10-K · filed 2024-09-26 |
| 2024-05-06 | 9.37M shares 10-Q · filed 2024-05-13 |
| 2024-02-02 | 2.59M shares 10-Q · filed 2024-02-13 |
| 2023-11-07 | 2.57M shares 10-Q · filed 2023-11-13 |
| 2023-08-16 | 2.55M shares 10-K · filed 2023-09-21 |
| 2023-05-11 | 27.98M shares 10-Q · filed 2023-05-15 |
| 2023-02-09 | 27.98M shares 10-Q · filed 2023-02-13 |
| 2022-11-09 | 27.98M shares 10-Q · filed 2022-11-10 |
| 2022-08-15 | 8.17M shares 10-K · filed 2022-09-02 |
| 2022-05-16 | 8.17M shares 10-Q · filed 2022-05-16 |
| 2022-02-10 | 8.17M shares 10-Q · filed 2022-02-14 |
| 2021-11-15 | 8.17M shares 10-Q · filed 2021-11-15 |
| 2021-09-07 | 8.17M shares 10-K · filed 2021-09-20 |
| 2021-05-06 | 7.85M shares 10-Q · filed 2021-05-12 |
| 2021-02-04 | 4.54M shares 10-Q · filed 2021-02-09 |
| 2020-11-09 | 4.41M shares 10-Q · filed 2020-11-13 |
| 2020-09-15 | 1.11M shares 10-K · filed 2020-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |